ArticlePloS one2025
Breast cancer pathology image recognition based on convolutional neural network.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a multimodal radiomics-serum biomarker model for diagnosing solid pulmonary nodules via machine learning.Journal of thoracic disease · 2025Article
- CVT-HNet: a fusion model for recognizing perianal fistulizing Crohn's disease based on CNN and ViT.BMC medical imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a convolutional neural network (CNN)-based method for the classification and recognition of breast cancer pathology images. It aims to solve the problems existing in traditional pathological tissue analysis methods, such as time-consuming and labour-intensive, and possible misdiagnosis or missed diagnosis. Using the idea of ensemble learning, the image is divided into four equal parts and sixteen equal parts for data augmentation. Then, using the Inception-ResNet V2 neural network model and transfer learning technology, features are extracted from pathological images, and a three-layer fully connected neural network is constructed for feature classification. In the recognition process of pathological image categories, the network first recognises each sub-image, and then sums and averages the recognition results of each sub-image to finally obtain the classification result. The experiment uses the BreaKHis dataset, which is a breast cancer pathological image classification dataset. It contains 7,909 images from 82 patients and covers benign and malignant lesion types. We randomly select 80% of the data as the training set and 20% as the test set and compare them with the Inception-ResNet V2, ResNet101, DenseNet169, MobileNetV3 and EfficientNetV2 models. Experimental results show that under the four magnifications of the BreaKHis dataset, the method used in this study achieves the highest accuracy rates of 99.75%, 98.31%, 98.51% and 96.69%, which are much higher than other models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.